ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

NCI awards $42 million for prevention trials consortium.

December 5, 2003

No Cancer Letter For Next Two Weeks

August 19, 1994

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007

In Brief: Hawaii Center Searching For New Director: Rosenberg Denies Report He’s Going To Tampa

June 7, 1985

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997

Kidney Cancer Group Seeks Proposals; AACR Offers Award

November 17, 1995